Novartis, which employs about 120,000 globally, is closing some of its research operations in Switzerland and China and cutting 175 jobs, according to a Reuters article. The company will also be relocating its tropical disease research arm from Singapore to California.
The company also announced it will be consolidating research oversight within its Swiss headquarters and the Novartis Institutes for Biomedical Research (NIBR) near Boston, Mass.
Read the Reuters article